Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of gynecology obstetrics and human reproduction"
DOI: 10.1016/j.jogoh.2021.102179
Abstract: INTRODUCTION Placental Growth Factor (PlGF) is used for the prediction of preeclampsia (PE), a syndrome associated with maternal vascular malperfusion (MVM). Our goal is to determine the correlation between PlGF and MVM. MATERIAL AND METHODS…
read more here.
Keywords:
plgf;
placental growth;
mvm;
growth factor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Placenta"
DOI: 10.1016/j.placenta.2018.07.017
Abstract: INTRODUCTION The biological mechanisms that underlie racial disparities in placenta-mediated pregnancy complications remain unknown. Placental evidence of maternal vascular malperfusion (MVM), a common pathologic feature of these outcomes, represents hypoxic-ischemic damage to the placenta. We…
read more here.
Keywords:
risk;
individual lesions;
vascular malperfusion;
race ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Placenta"
DOI: 10.1016/j.placenta.2019.09.003
Abstract: INTRODUCTION To study the association between placental pathology and neonatal birthweight and outcomes, and whether a combination of first trimester biomarkers and fetal growth velocity can predict placental lesions. METHODS The presence of maternal vascular…
read more here.
Keywords:
neonatal birthweight;
mvm lesions;
fetal growth;
growth ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Placenta"
DOI: 10.1016/j.placenta.2020.10.035
Abstract: INTRODUCTION Abnormal levels of first trimester placental biomarkers are associated with the development of placental syndrome (PS). However, prediction performance is moderate, possibly explained by the clinical heterogeneity of PS. Aim of this study is…
read more here.
Keywords:
placental biomarkers;
association first;
trimester placental;
vascular malperfusion ... See more keywords